The Future of CML Treatment: What’s Next?

Topics Covered

We invite you to learn more about:

• Novel treatments for chronic myeloid leukemia (CML)
• The importance of monitoring your CML
• Effectively managing side effects
• Communication with your treatment team

Program Materials

Speaker

Vivian G. Oehler, MD
Associate Professor, Division of
Translational Science and Therapeutics
Fred Hutchinson Cancer Center Division of Hematology/Oncology
University of Washington
Seattle, WA

Program Support

Support for this program provided by Novartis Pharmaceuticals Corporation.

< Back to Webcasts